Identity & Access Management · head-to-head
CyberArk vs IBM Security Identity
On-prem IAM/IGA/PAM/MFA: directories, federation, privileged access, SSO. Counts are scoped to this segment and the selected published-date window. IBM Security Identity carries 13.0× the disclosed CVE volume of CyberArk. Volume reflects disclosure practice and install base as much as code quality — read it with the severity mix. Sourced from the NIST NVD; lower counts indicate a smaller disclosed vulnerability surface — not necessarily lower risk.
Disclosure record
Bars are normalized per row to the larger value; the leading count is emphasized.
| CyberArk | Metric | IBM Security Identity | ||
|---|---|---|---|---|
| 2 | Total CVEs | 26 | ||
| 0 | Critical | 2 | ||
| 2 | High | 13 | ||
| 0 | Medium | 8 | ||
| 0 | Low | 3 | ||
| 6 | Open in latest | 107 |
Risk profile
Each severity band as a share of the vendor's own total — strips out raw volume so the profiles compare directly.
CyberArk
0.0% critical- Critical
- 00.0%
- High
- 2100.0%
- Medium
- 00.0%
- Low
- 00.0%
IBM Security Identity
7.7% critical- Critical
- 27.7%
- High
- 1350.0%
- Medium
- 830.8%
- Low
- 311.5%
Recent activity
Latest in-window disclosures per vendor, newest first. Each ID links to its NVD record.
CyberArk
| CVE | Severity | CVSS | Published |
|---|---|---|---|
| CVE-2026-2914(opens NVD record) | High | 7.8 | Feb 25, 2026 |
| CVE-2025-66374(opens NVD record) | High | 7.8 | Feb 3, 2026 |
IBM Security Identity
| CVE | Severity | CVSS | Published |
|---|---|---|---|
| CVE-2026-17616(opens NVD record) | Medium | 6.8 | Aug 12, 2026 |
| CVE-2026-11932(opens NVD record) | Medium | 5.3 | Aug 12, 2026 |
| CVE-2026-13267(opens NVD record) | High | 8.1 | Aug 12, 2026 |
| CVE-2026-12618(opens NVD record) | High | 7.2 | Aug 12, 2026 |
| CVE-2026-12359(opens NVD record) | High | 8.1 | Aug 12, 2026 |
| CVE-2026-12005(opens NVD record) | High | 7.2 | Aug 12, 2026 |
Track new CVEs for these vendors
Get an email the moment a new vulnerability is disclosed for the products you rely on.